Drug Information
Drug (ID: DG01690) and It's Reported Resistant Information
| Name |
Binimetinib/Everolimus
|
||||
|---|---|---|---|---|---|
| Synonyms |
Binimetinib/Everolimus
Click to Show/Hide
|
||||
Type(s) of Resistant Mechanism of This Drug
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Key Molecule: GTPase Hras (HRAS) | [1] | |||
| Sensitive Disease | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | |||
| Molecule Alteration | Missense mutation | p.Q61L (c.182A>T) |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | T24 cells | Bladder | Homo sapiens (Human) | CVCL_0554 |
| Ba/F3 cells | Colon | Homo sapiens (Human) | CVCL_0161 | |
| RL952 cells | Endometrium | Homo sapiens (Human) | CVCL_0505 | |
| NCI-H1915 cells | Lung | Homo sapiens (Human) | CVCL_1505 | |
| KYSE-30 cells | Esophagus | Homo sapiens (Human) | CVCL_1351 | |
| KNS62 cells | Brain | Homo sapiens (Human) | CVCL_1335 | |
| HCC78 cells | Pleural effusion | Homo sapiens (Human) | CVCL_2061 | |
| HCC44 cells | Lung | Homo sapiens (Human) | CVCL_2060 | |
| CAL-12T cells | Lung | Homo sapiens (Human) | CVCL_1105 | |
| In Vivo Model | CB17 SCID-/- mouse xenograft model | Mus musculus | ||
| Experiment for Molecule Alteration |
Western blot analysis | |||
| Experiment for Drug Resistance |
CellTiter-Glo assay | |||
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | |||||||||||||
|
|
|||||||||||||
| Key Molecule: GTPase Hras (HRAS) | [1] | ||||||||||||
| Sensitive Disease | Bladder cancer [ICD-11: 2C94.0] | ||||||||||||
| Molecule Alteration | Missense mutation | p.G12V (c.35G>T) |
|||||||||||
| Wild Type Structure | Method: X-ray diffraction | Resolution: 1.98 Å | |||||||||||
| Mutant Type Structure | Method: X-ray diffraction | Resolution: 1.96 Å | |||||||||||
| Download The Information of Sequence | Download The Structure File | ||||||||||||
-
G
-
0
|
S
-
M
M
T
T
E
E
Y
Y
K
K
L
L
V
V
V
V
V
V
10
|
G
G
A
A
G
V
G
G
V
V
G
G
K
K
S
S
A
A
L
L
20
|
T
T
I
I
Q
Q
L
L
I
I
Q
Q
N
N
H
H
F
F
V
V
30
|
D
D
E
E
Y
Y
D
D
P
P
T
T
I
I
E
E
D
D
S
S
40
|
Y
Y
R
R
K
K
Q
Q
V
V
V
V
I
I
D
D
G
G
E
E
50
|
T
T
C
C
L
L
L
L
D
D
I
I
L
L
D
D
T
T
A
A
60
|
G
G
Q
Q
E
E
E
E
Y
Y
S
S
A
A
M
M
R
R
D
D
70
|
Q
Q
Y
Y
M
M
R
R
T
T
G
G
E
E
G
G
F
F
L
L
80
|
C
C
V
V
F
F
A
A
I
I
N
N
N
N
T
T
K
K
S
S
90
|
F
F
E
E
D
D
I
I
H
H
H
H
Y
Y
R
R
E
E
Q
Q
100
|
I
I
K
K
R
R
V
V
K
K
D
D
S
S
E
E
D
D
V
V
110
|
P
P
M
M
V
V
L
L
V
V
G
G
N
N
K
K
S
S
D
D
120
|
L
L
P
P
S
S
R
R
T
T
V
V
D
D
T
T
K
K
Q
Q
130
|
A
A
Q
Q
D
D
L
L
A
A
R
R
S
S
Y
Y
G
G
I
I
140
|
P
P
F
F
I
I
E
E
T
T
S
S
A
A
K
K
T
T
R
R
150
|
Q
Q
G
G
V
V
D
D
D
D
A
A
F
F
Y
Y
T
T
L
L
160
|
V
V
R
R
E
E
I
I
R
R
K
K
H
H
K
K
E
E
K
K
170
|
M
M
S
S
K
K
D
D
G
G
K
K
K
K
K
K
K
K
K
K
180
|
K
K
S
S
K
K
T
T
K
K
C
C
V
V
I
I
M
M
|
|||||||||||||
| Experimental Note | Revealed Based on the Cell Line Data | ||||||||||||
| In Vitro Model | T24 cells | Bladder | Homo sapiens (Human) | CVCL_0554 | |||||||||
| Ba/F3 cells | Colon | Homo sapiens (Human) | CVCL_0161 | ||||||||||
| RL952 cells | Endometrium | Homo sapiens (Human) | CVCL_0505 | ||||||||||
| NCI-H1915 cells | Lung | Homo sapiens (Human) | CVCL_1505 | ||||||||||
| KYSE-30 cells | Esophagus | Homo sapiens (Human) | CVCL_1351 | ||||||||||
| KNS62 cells | Brain | Homo sapiens (Human) | CVCL_1335 | ||||||||||
| HCC78 cells | Pleural effusion | Homo sapiens (Human) | CVCL_2061 | ||||||||||
| HCC44 cells | Lung | Homo sapiens (Human) | CVCL_2060 | ||||||||||
| CAL-12T cells | Lung | Homo sapiens (Human) | CVCL_1105 | ||||||||||
| In Vivo Model | CB17 SCID-/- mouse xenograft model | Mus musculus | |||||||||||
| Experiment for Molecule Alteration |
Western blot analysis | ||||||||||||
| Experiment for Drug Resistance |
CellTiter-Glo assay | ||||||||||||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
